Tag: Cancer: Prostate

High satisfaction reported for genetic testing model including education, follow-up with genetic counselor

Triplet therapy should be offered to patients with de novo metastatic noncastrate prostate cancer with high-volume disease

However, significant differences in use seen by race/ethnicity, education, and geography

Risk for all-cause mortality up for men receiving post-radical prostatectomy salvage radiation therapy at PSA level >0.25 ng/mL

Higher associations seen for those with lower intakes of fiber, fruit/vegetables, and vitamin C

Seventeen variants identified as potentially oncogenic in 17.7 percent of South African male patients

Among men analyzed with DRE as solitary screening test for prostate cancer, suspicious findings did not increase prostate cancer detection

Considerable variation observed in active surveillance use, from 4.0 to 78.0 percent at practice level and from 0 to 100 percent at practitioner level

Multiancestry polygenic risk score can stratify prostate cancer risk and differentiate risk for aggressive disease

Findings seen for men treated with enzalutamide for nonmetastatic castration-resistant prostate cancer